IRIS Accounts Production v25.1.4.42 08081298 director 1.8.23 31.7.24 31.7.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh080812982023-07-31080812982024-07-31080812982023-08-012024-07-31080812982022-07-31080812982022-08-012023-07-31080812982023-07-3108081298ns15:EnglandWales2023-08-012024-07-3108081298ns14:PoundSterling2023-08-012024-07-3108081298ns10:Director12023-08-012024-07-3108081298ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3108081298ns10:SmallEntities2023-08-012024-07-3108081298ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3108081298ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3108081298ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3108081298ns10:FullAccounts2023-08-012024-07-310808129812023-08-012024-07-3108081298ns10:RegisteredOffice2023-08-012024-07-3108081298ns5:CurrentFinancialInstruments2024-07-3108081298ns5:CurrentFinancialInstruments2023-07-3108081298ns5:ShareCapital2024-07-3108081298ns5:ShareCapital2023-07-3108081298ns5:RetainedEarningsAccumulatedLosses2024-07-3108081298ns5:RetainedEarningsAccumulatedLosses2023-07-3108081298ns5:NetGoodwill2023-08-012024-07-3108081298ns5:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3108081298ns5:PlantMachinery2023-08-012024-07-3108081298ns5:FurnitureFittings2023-08-012024-07-3108081298ns5:ComputerEquipment2023-08-012024-07-3108081298ns5:NetGoodwill2023-07-3108081298ns5:NetGoodwill2024-07-3108081298ns5:NetGoodwill2023-07-3108081298ns5:LongLeaseholdAssetsns5:LandBuildings2023-07-3108081298ns5:PlantMachinery2023-07-3108081298ns5:FurnitureFittings2023-07-3108081298ns5:ComputerEquipment2023-07-3108081298ns5:LongLeaseholdAssetsns5:LandBuildings2023-08-012024-07-3108081298ns5:LongLeaseholdAssetsns5:LandBuildings2024-07-3108081298ns5:PlantMachinery2024-07-3108081298ns5:FurnitureFittings2024-07-3108081298ns5:ComputerEquipment2024-07-3108081298ns5:LongLeaseholdAssetsns5:LandBuildings2023-07-3108081298ns5:PlantMachinery2023-07-3108081298ns5:FurnitureFittings2023-07-3108081298ns5:ComputerEquipment2023-07-3108081298ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3108081298ns5:WithinOneYearns5:CurrentFinancialInstruments2023-07-31080812981ns10:Director12023-07-31080812981ns10:Director12022-07-31080812981ns10:Director12023-08-012024-07-31080812981ns10:Director12022-08-012023-07-31080812981ns10:Director12024-07-31080812981ns10:Director12023-07-31
REGISTERED NUMBER: 08081298 (England and Wales)



















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST JULY 2024

FOR

DR ROWLAND PAYNE DERMATOLOGY LTD

DR ROWLAND PAYNE DERMATOLOGY LTD (REGISTERED NUMBER: 08081298)

CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31st July 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


DR ROWLAND PAYNE DERMATOLOGY LTD

COMPANY INFORMATION
for the year ended 31st July 2024







DIRECTOR: Dr. C M E Rowland-Payne





REGISTERED OFFICE: 20 Bramerton Street
Chelsea
London
SW3 5JX





REGISTERED NUMBER: 08081298 (England and Wales)





ACCOUNTANTS: Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB

DR ROWLAND PAYNE DERMATOLOGY LTD (REGISTERED NUMBER: 08081298)

BALANCE SHEET
31st July 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 551,874 566,397
Tangible assets 5 92,653 102,568
644,527 668,965

CURRENT ASSETS
Debtors 6 12,405 13,077
Investments 7 1,652,811 1,230,805
Cash at bank 260,301 123,753
1,925,517 1,367,635
CREDITORS
Amounts falling due within one year 8 323,182 347,202
NET CURRENT ASSETS 1,602,335 1,020,433
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,246,862

1,689,398

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 2,246,762 1,689,298
SHAREHOLDERS' FUNDS 2,246,862 1,689,398

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st July 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

DR ROWLAND PAYNE DERMATOLOGY LTD (REGISTERED NUMBER: 08081298)

BALANCE SHEET - continued
31st July 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 9th June 2025 and were signed by:





Dr. C M E Rowland-Payne - Director


DR ROWLAND PAYNE DERMATOLOGY LTD (REGISTERED NUMBER: 08081298)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31st July 2024


1. STATUTORY INFORMATION

Dr Rowland Payne Dermatology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2012, is being amortised evenly over its estimated useful life of fifty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on cost
Fixtures and fittings - 25% on cost
Computer equipment - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


DR ROWLAND PAYNE DERMATOLOGY LTD (REGISTERED NUMBER: 08081298)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31st July 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 16 (2023 - 12 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1st August 2023
and 31st July 2024 726,150
AMORTISATION
At 1st August 2023 159,753
Charge for year 14,523
At 31st July 2024 174,276
NET BOOK VALUE
At 31st July 2024 551,874
At 31st July 2023 566,397

DR ROWLAND PAYNE DERMATOLOGY LTD (REGISTERED NUMBER: 08081298)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31st July 2024


5. TANGIBLE FIXED ASSETS
Fixtures
Lease & Plant and and Computer
improvements machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1st August 2023 117,214 87,231 73,269 22,981 300,695
Additions - 3,942 9,853 2,145 15,940
At 31st July 2024 117,214 91,173 83,122 25,126 316,635
DEPRECIATION
At 1st August 2023 59,385 65,679 53,497 19,566 198,127
Charge for year 6,425 8,243 9,171 2,016 25,855
At 31st July 2024 65,810 73,922 62,668 21,582 223,982
NET BOOK VALUE
At 31st July 2024 51,404 17,251 20,454 3,544 92,653
At 31st July 2023 57,829 21,552 19,772 3,415 102,568

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 12,405 10,375
Directors' current accounts - 2,702
12,405 13,077

7. CURRENT ASSET INVESTMENTS
2024 2023
£    £   
Listed investments 1,652,811 1,230,805

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Tax 265,404 328,098
Directors' current accounts 26,688 -
Accruals and deferred income 31,090 19,104
323,182 347,202

DR ROWLAND PAYNE DERMATOLOGY LTD (REGISTERED NUMBER: 08081298)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31st July 2024


9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31st July 2024 and 31st July 2023:

2024 2023
£    £   
Dr. C M E Rowland-Payne
Balance outstanding at start of year - (2,215 )
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - -

10. ULTIMATE CONTROLLING PARTY

The controlling party is Dr. C M E Rowland-Payne.